Individuals Coming Off Slimming Medications Regain Weight Four Times Faster Than Dieters

A recent study reveals that patients who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who halt conventional lifestyle plans.

Published data in a major health publication points out that while obese individuals often shed a large proportion of their body weight while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month after stopping.

"Users purchasing such medications should be informed of the risk of rapid weight regain when the treatment ends," cautioned lead investigator Dr. Susan Jebb.

This pace of recovery implies a reversion to starting weight within about one and a half years.

Comparing Treatments

The analysis, which reviewed dozens of trials involving thousands of participants, compared the effects of GLP-1 agonists with older methods.

Researchers emphasize that individuals who lose weight through dieting generally experience a slower weight regain—perhaps 100 grams monthly—once they finish.

Explaining the Quick Regain

Experts propose the mode of action of the jabs is key to understanding the heightened regain.

These medications imitate a natural hormone called glucagon-like peptide-1, which controls appetite.

"Long-term administration of the hormone concentrations several times higher than the body's typical production may cause the body to produce less of its own natural GLP-1, and could diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.

"Discontinuation of this hormone supplement results in hunger is unsuppressed, making excessive eating far more likely."

An Ongoing Condition?

The NHS advise the jabs for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.

Professionals contend that, due to the significant potential of weight regain, the treatment should be considered ongoing.

This opinion is reinforced by pharmaceutical companies, who say that the findings "underscore the chronic character of excess weight," comparing it to managing diseases like high blood pressure.

User Accounts

Users who have discontinued the jabs report a powerful return of appetite.

"It felt as if a switch that goes on and you become ravenous," recalled one woman.

The struggle is compounded if patients have not established sustainable lifestyle or habit modifications during therapy.

Growing Use

Recent estimates indicate that millions of adults in the UK have used weight-loss jabs in the past year, with interest continuing to grow.

• Use is greater among women compared to men.
• The 40s and 50s age group shows the greatest level of interest.
• A large proportion obtain the medications through private healthcare rather than public health services.

In conclusion, clinicians stress that while these medications are powerful tools for shedding pounds, they are not a permanent solution and maintained weight loss hinges on ongoing lifestyle changes.